Compare $CELZ vs $LNAI | Chartloom

Compare

$CELZ vs $LNAI

Creative Medical Technology Holdings Inc · Lunai Bioworks Inc

CELZ

Creative Medical Technology Holdings Inc

LNAI

Lunai Bioworks Inc

Compare $CELZ vs $LNAI

Comparing Creative Medical Technology Holdings Inc and Lunai Bioworks Inc

CELZCreative Medical Technology Holdings Inc

LNAILunai Bioworks Inc

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

LNAILunai Bioworks Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.2%

52W performance

-87.6%

FCF yield

-94.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELZ

LNAI

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

LNAI

Lunai Bioworks Inc

Market Cap

CELZ$4M

LNAI$6M

Enterprise Value

CELZ$-5M

LNAI$3M

Price

CELZ$0.84

LNAI$1.23

P/E Ratio

CELZN/A

LNAIN/A

P/S Ratio

CELZ1,324.83x

LNAI266.60x

EV/Sales

CELZ-1,579.87x

LNAI163.08x

EV/EBITDA

CELZ0.00x

LNAI0.00x

P/B Ratio

CELZ0.72x

LNAI0.07x

P/FCF Ratio

CELZN/A

LNAIN/A

EV/FCF

CELZ0.80x

LNAI-0.65x

PEG Ratio

CELZN/A

LNAIN/A

Forward P/E (NTM)

CELZN/A

LNAIN/A

Forward P/S (NTM)

CELZN/A

LNAIN/A

Revenue (TTM)

CELZ$3K

LNAI$21K

Revenue Growth (YoY)

CELZ-50.0%

LNAIN/A

Forward Rev Growth

CELZ56.2%

LNAI0.0%

Gross Margin (TTM)

CELZ66.7%

LNAI0.0%

Operating Margin (TTM)

CELZ0.0%

LNAI0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

LNAI-46584.2%

Net Margin (TTM)

CELZ-201356.7%

LNAI-613799.0%

FCF Margin (TTM)

CELZ-196726.7%

LNAI-25165.1%

Net Income (TTM)

CELZ$-6M

LNAI$-128M

FCF (TTM)

CELZ$-6M

LNAI$-5M

EPS (TTM)

CELZ-$1.63

LNAI-$41.06

ROE (TTM)

CELZ-8670.0%

LNAI-6700.0%

ROA (TTM)

CELZ-8196.0%

LNAI-161778.0%

ROIC (TTM)

CELZ-8670.0%

LNAI-6439.0%

Cash

CELZ$9M

LNAI$3M

Debt

CELZ$0

LNAI$992K

Net Cash/Debt

CELZ$9M

LNAI$2M

Current Ratio (TTM)

CELZ12.91x

LNAI0.19x

Quick Ratio (TTM)

CELZ12.63x

LNAI0.16x

Debt/Equity (TTM)

CELZ0.00x

LNAI0.07x

Debt/Assets (TTM)

CELZ0.0%

LNAI0.0%

Interest Coverage (TTM)

CELZN/A

LNAIN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

LNAI0.00x

Beta

CELZ1.93

LNAI0.32

52W Performance

CELZ-76.5%

LNAI-87.6%

YTD Performance

CELZ-57.4%

LNAI-84.2%

% from 52W High

CELZ-86.6%

LNAI-90.7%

% from 52W Low

CELZ35.2%

LNAI40.5%

Asset Turnover (TTM)

CELZ0.00x

LNAI0.00x

FCF Yield (TTM)

CELZ-148.5%

LNAI-94.4%

Earnings Yield (TTM)

CELZ-152.0%

LNAI-2302.3%

Dividend Yield (TTM)

CELZN/A

LNAIN/A

Rule of 40

CELZ-196,776.7

LNAI-25,165.1

EV/GP/RG

CELZN/A

LNAIN/A

Ticker research

View CELZ research View LNAI research

Metric	CELZ Creative Medical Technology Holdings Inc	LNAI Lunai Bioworks Inc
Market & Valuation
Market Cap	$4M	$6M
Enterprise Value	$-5M	$3M
Price	$0.84	$1.23
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	266.60x
EV/Sales	-1,579.87x	163.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$21K
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	-46584.2%
Net Margin (TTM)	-201356.7%	-613799.0%
FCF Margin (TTM)	-196726.7%	-25165.1%
Net Income (TTM)	$-6M	$-128M
FCF (TTM)	$-6M	$-5M
EPS (TTM)	-$1.63	-$41.06
ROE (TTM)	-8670.0%	-6700.0%
ROA (TTM)	-8196.0%	-161778.0%
ROIC (TTM)	-8670.0%	-6439.0%
Financial Health
Cash	$9M	$3M
Debt	$0	$992K
Net Cash/Debt	$9M	$2M
Current Ratio (TTM)	12.91x	0.19x
Quick Ratio (TTM)	12.63x	0.16x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	0.32
52W Performance	-76.5%	-87.6%
YTD Performance	-57.4%	-84.2%
% from 52W High	-86.6%	-90.7%
% from 52W Low	35.2%	40.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-148.5%	-94.4%
Earnings Yield (TTM)	-152.0%	-2302.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	-25,165.1
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View LNAI research

Valuation

P/S Ratio

LNAI

266.60x

CELZ

1,324.83x

EV/FCF

LNAI

-0.65x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

CELZ

-50.0%

Forward Revenue Growth

CELZ

56.2%

LNAI

0.0%

Profitability & performance

Gross Margin

CELZ

66.7%

LNAI

0.0%

ROE

LNAI

-6700.0%

CELZ

-8670.0%

FCF Yield %

LNAI

-94.4%

CELZ

-148.5%

52-Week Performance

CELZ

-76.5%

LNAI

-87.6%

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

LNAI

Lunai Bioworks Inc

Market Cap

CELZ$4M

LNAI$6M

Enterprise Value

CELZ$-5M

LNAI$3M

Price

CELZ$0.84

LNAI$1.23

P/E Ratio

CELZN/A

LNAIN/A

P/S Ratio

CELZ1,324.83x

LNAI266.60x

EV/Sales

CELZ-1,579.87x

LNAI163.08x

EV/EBITDA

CELZ0.00x

LNAI0.00x

P/B Ratio

CELZ0.72x

LNAI0.07x

P/FCF Ratio

CELZN/A

LNAIN/A

EV/FCF

CELZ0.80x

LNAI-0.65x

PEG Ratio

CELZN/A

LNAIN/A

Forward P/E (NTM)

CELZN/A

LNAIN/A

Forward P/S (NTM)

CELZN/A

LNAIN/A

Revenue (TTM)

CELZ$3K

LNAI$21K

Revenue Growth (YoY)

CELZ-50.0%

LNAIN/A

Forward Rev Growth

CELZ56.2%

LNAI0.0%

Gross Margin (TTM)

CELZ66.7%

LNAI0.0%

Operating Margin (TTM)

CELZ0.0%

LNAI0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

LNAI-46584.2%

Net Margin (TTM)

CELZ-201356.7%

LNAI-613799.0%

FCF Margin (TTM)

CELZ-196726.7%

LNAI-25165.1%

Net Income (TTM)

CELZ$-6M

LNAI$-128M

FCF (TTM)

CELZ$-6M

LNAI$-5M

EPS (TTM)

CELZ-$1.63

LNAI-$41.06

ROE (TTM)

CELZ-8670.0%

LNAI-6700.0%

ROA (TTM)

CELZ-8196.0%

LNAI-161778.0%

ROIC (TTM)

CELZ-8670.0%

LNAI-6439.0%

Cash

CELZ$9M

LNAI$3M

Debt

CELZ$0

LNAI$992K

Net Cash/Debt

CELZ$9M

LNAI$2M

Current Ratio (TTM)

CELZ12.91x

LNAI0.19x

Quick Ratio (TTM)

CELZ12.63x

LNAI0.16x

Debt/Equity (TTM)

CELZ0.00x

LNAI0.07x

Debt/Assets (TTM)

CELZ0.0%

LNAI0.0%

Interest Coverage (TTM)

CELZN/A

LNAIN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

LNAI0.00x

Beta

CELZ1.93

LNAI0.32

52W Performance

CELZ-76.5%

LNAI-87.6%

YTD Performance

CELZ-57.4%

LNAI-84.2%

% from 52W High

CELZ-86.6%

LNAI-90.7%

% from 52W Low

CELZ35.2%

LNAI40.5%

Asset Turnover (TTM)

CELZ0.00x

LNAI0.00x

FCF Yield (TTM)

CELZ-148.5%

LNAI-94.4%

Earnings Yield (TTM)

CELZ-152.0%

LNAI-2302.3%

Dividend Yield (TTM)

CELZN/A

LNAIN/A

Rule of 40

CELZ-196,776.7

LNAI-25,165.1

EV/GP/RG

CELZN/A

LNAIN/A

Ticker research

View CELZ research View LNAI research

Metric	CELZ Creative Medical Technology Holdings Inc	LNAI Lunai Bioworks Inc
Market & Valuation
Market Cap	$4M	$6M
Enterprise Value	$-5M	$3M
Price	$0.84	$1.23
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	266.60x
EV/Sales	-1,579.87x	163.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$21K
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	-46584.2%
Net Margin (TTM)	-201356.7%	-613799.0%
FCF Margin (TTM)	-196726.7%	-25165.1%
Net Income (TTM)	$-6M	$-128M
FCF (TTM)	$-6M	$-5M
EPS (TTM)	-$1.63	-$41.06
ROE (TTM)	-8670.0%	-6700.0%
ROA (TTM)	-8196.0%	-161778.0%
ROIC (TTM)	-8670.0%	-6439.0%
Financial Health
Cash	$9M	$3M
Debt	$0	$992K
Net Cash/Debt	$9M	$2M
Current Ratio (TTM)	12.91x	0.19x
Quick Ratio (TTM)	12.63x	0.16x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	0.32
52W Performance	-76.5%	-87.6%
YTD Performance	-57.4%	-84.2%
% from 52W High	-86.6%	-90.7%
% from 52W Low	35.2%	40.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-148.5%	-94.4%
Earnings Yield (TTM)	-152.0%	-2302.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	-25,165.1
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View LNAI research